Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROS-CONS: Prolonged vs Short Corticosteroids for Checkpoint Inhibitor Pneumonitis
NCT04036721Phase 4Suspended
- Start
- Oct 2019
- Primary completion
- Feb 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone in Checkpoint inhibitor pneumonitis (CIP). Started Oct 2019; status: suspended.
02
Drugs
prednisone
03
Conditions
Checkpoint inhibitor pneumonitis (CIP)
Beyond the preview
Go deeper on NCT04036721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04036721.